26 February 1996 00:00 [Source: ICB]
Zeneca Pharmaceuticals has opened a bulk drug manufacturing plant at its Avlon site in Bristol, UK. The plant will supply extra capacity for the production of tamoxifen, the active component in Nolvadex which is used in the treatment of breast cancer. The £14m ($21m) plant is part of the company's £1.5bn investment programme.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|
Asian Chemical Connections